![Jerry T. Jackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jerry T.
Jackson has been a Director of Alexion Pharmaceuticals, Inc. since September 1999.
Previously, he was a Director of Myogen, Inc., Langford I.C.
Systems, Inc. and Intrabiotics Pharmaceuticals, Inc. Mr. Jackson worked for Merck & Co., Inc. from 1965 to 1995.
He received a BA degree from the University of New Mexico.
| Companies | Position | End |
|---|---|---|
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Director/Board Member | 2007-01-21 |
| ALEXION PHARMACEUTICALS, INC. | Director/Board Member | - |
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cardiovascular diseases | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cardiovascular diseases | Health Technology |
The University of New Mexico
 The University of New Mexico Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
